Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-18

FDA Approved: TPOXX — Original Application (SIGA Technologies, Inc.)

View source ↗

Summary

The FDA approved TPOXX (tecovirimat monohydrate) from SIGA Technologies under original NDA 214518 for the treatment of smallpox in adults and pediatric patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TPOXX (tecovirimat monohydrate)

Snippet

ORIG AP for TPOXX (TECOVIRIMAT MONOHYDRATE)